Opportunities
Search

This result matches because the title matches the main search terms, the type, category, tags, or source metadata support the match, the applicant profile aligns with startups.

Applicant type: Company.

Deadline: Nov 15, 2027.

The purpose of this Notice of Funding Opportunity (NOFO) is to leverage NICHD clinical research Network infrastructure relevant to infants, children, women, pregnant and lactating women, and persons with disabilities to conduct innovative, multisite, investigator-initiated clinical trials and observational studies. This NOFO will utilize a bi-phasic (UG3/UH3), milestone-driven mechanism consisting of a start-up phase (UG3) and a full enrollment and clinical trial implementation phase (UH3). Applications submitted in response to this NOFO must address specific aims and milestones for both the UG3 and UH3 phases. A UG3 project (phase I) that meets its milestones will be administratively considered by NICHD and prioritized for transition to the UH3 award (phase II). This NOFO provides an opportunity to leverage NICHD clinical research Network infrastructure as a platform for investigator-initiated innovative hypotheses by any investigator in the extramural community. Applications must be submitted as investigator-initiated, multi-Project Director/Principal Investigator (PD/PI) grant applications in conjunction with the respective NICHD-supported Network Data Coordinating Center (DCC), or equivalent as determined by the NICHD.

This result matches because the type, category, tags, or source metadata support the match, the applicant profile aligns with startups, the summary or source description contains related terms.

Applicant type: Company.

Deadline: Jul 30, 2026.

The Office of Community Oriented Policing Services (COPS) is the component of the U.S. Department of Justice responsible for advancing the practice of community policing and the Administration’s priority of Making America Safe Again by supporting the nation’s state, local, territorial and Tribal law enforcement agencies through information and grant resources. This is a notice of funding opportunity (NOFO) for the FY26 Law Enforcement Mental Health and Wellness Act (LEMHWA) Program. The mental health and wellness of law enforcement officers and their families is a priority of the Administration. Through the LEMHWA program, the Department of Justice supports this priority by providing funding directly to state, local, tribal, and territorial (SLTT) law enforcement agencies to implement new or enhance existing programs that offer training and services to support officers emotional and mental health including, counseling programs, peer mentoring, suicide prevention, stress reduction, and police officer family services. As community policing is common sense policing, throughout the FY26 LEMHWA program NOFO materials, the terms “community policing” and “common sense policing” are used interchangeably, unless otherwise specified. The COPS Office seeks to increase the delivery of and access to mental health and wellness services through this NOFO in the following three funding categor...

This result matches because the type, category, tags, or source metadata support the match, the applicant profile aligns with startups, the summary or source description contains related terms.

Applicant type: Company.

Deadline: Apr 5, 2029.

The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).

This result matches because the type, category, tags, or source metadata support the match, the applicant profile aligns with startups, the summary or source description contains related terms.

Applicant type: Company.

Deadline: Jan 7, 2027.

The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting clinical trial start-up and implementation activities, this FOA will provide support for final stage preclinical activities needed for the implementation of the proposed trial. All the activities proposed in the R61 phase must be directly related to the therapeutic/diagnostic in preparation for the clinical trial. The proposed trial can be single or multisite. This NOFO will utilize a bi-phasic, milestone-driven mechanism of award where the first phase can be used to finalize required pre-trial activities such as stability, shipping studies, and site training.